Personalized medicine in Alzheimer's disease and depression.
about
Biomarkers in pediatric depressionUsing patient self-reports to study heterogeneity of treatment effects in major depressive disorder.The gastrointestinal tract microbiome and potential link to Alzheimer's disease.In vivo and in vitro studies on the roles of p38 mitogen-activated protein kinase and NADPH-cytochrome P450 reductase in Alzheimer's disease.Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.
P2860
Personalized medicine in Alzheimer's disease and depression.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Personalized medicine in Alzheimer's disease and depression.
@ast
Personalized medicine in Alzheimer's disease and depression.
@en
type
label
Personalized medicine in Alzheimer's disease and depression.
@ast
Personalized medicine in Alzheimer's disease and depression.
@en
prefLabel
Personalized medicine in Alzheimer's disease and depression.
@ast
Personalized medicine in Alzheimer's disease and depression.
@en
P2093
P1476
Personalized medicine in Alzheimer's disease and depression.
@en
P2093
A Michael Spiekerman
Amin A Mohammad
Tatiana Souslova
Teresa C Marple
P304
P356
10.1016/J.CCT.2013.06.012
P407
P577
2013-06-29T00:00:00Z